HOME >> MEDICINE >> NEWS
Integrative Cancer Therapies journal accepted into prestigious ISI index

tice or Exercise Intervention? Studying the Benefit for Cancer Survivors"

"Extraction-Dependent Effects of American Ginseng (Panax quinquifolium) on Human Breast Cancer Cell Proliferation and Estrogen Receptor Activation"

Preadministration of High-Dose Salicylates, Suppressors of NF-kB Activation, May Increase the Chemosensitivity of Many Cancers

"Integrative cancer treatment incorporates the best of conventional interventions with meaningful, complementary therapies, and individualizes each patient's care regimen. Treatment plans may include chemotherapy, chronomodulated chemotherapy (circadian-timed chemotherapy), prescriptive exercise, nutritional pharmacology, scientifically tailored supplements, mind/body work and physical therapy," Dr. Block explains. "This acknowledgment by ISI will help professionals and patients alike understand ICT is a forum for disseminating information about groundbreaking and forward-looking work and I congratulate our editorial staff, editorial and advisory boards, and contributors to ICT for this important recognition."


'"/>

Contact: Judy Erickson
media.inquiries@sagepub.com
SAGE Publications
25-Sep-2006


Page: 1 2

Related medicine news :

1. Embargoed materials for Complementary & Integrative Medicine Conference
2. American Cancer Society to hold third annual Virtual Relay For Life in Second Life
3. Cancer research summaries
4. Cancer on the agenda of the Portuguese EU Council Presidency
5. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research
6. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
7. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
8. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
9. Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer
10. Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
11. Margaret Foti receives AACR Award for Leadership and Extraordinary Achievements in Cancer Research

Post Your Comments:
(Date:3/28/2015)... Aureus Medical Group (web: aureusmedical.com), ... therapy jobs, has announced that it will participate ... Association Annual Conference to be held April 10-11, ... Columbus, OH. , The OPTA Annual Conference ... products and services. , Representatives from Aureus ...
(Date:3/28/2015)... Designers and Professionals of FCPX ... 5K from Pixel Film Studios. , “Scratches 5K allows ... inside Final Cut Pro X” Said Christina Austin, CEO ... is an effective tool for any FCPX editor.” , ... intuitive grunge overlays. Simply drag title layers into the ...
(Date:3/28/2015)... CA (PRWEB) March 28, 2015 ... specialists , this week released a report about the ... symptoms of asthma sufferers, and according to recent medical ... , According to the Environmental Protection Agency, people ... asthmatic reactions. Breathing in mold may trigger asthma attacks ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Wellness for ... and business criteria for the spa and wellness industry–has ... clients who have experienced or are living with cancer. ... Spafinder Wellness 365® Network, will be identified with a ... as a provider of safe, therapeutic services for cancer ...
(Date:3/27/2015)... York (PRWEB) March 27, 2015 The ... ) that allege the statin medication increases the risk ... granted Pfizer Inc.’s Motion to Dismiss four individual cases ... a Case Management Order issued in the U.S. District ... Court determined that the dismissals were warranted because the ...
Breaking Medicine News(10 mins):Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3
(Date:3/27/2015)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) ... announced registered offering of common shares in ... the Offering, the Company issued 7,286,432 common shares at ... proceeds of approximately $1.45 billion. On March 18, 2015, ... Commission a final prospectus supplement to its effective shelf ...
(Date:3/27/2015)... March 27, 2015 As of February, ... incontinence devices for women. "Shipping thousands ... gratifying part is the hundreds of letters, emails ... lives have been positively impacted by our technology," ... InControl recently released Apex, an over-the-counter ...
(Date:3/27/2015)... 2015   Hospira, Inc. (NYSE: ... the world,s leading provider of injectable drugs and ... evaluation of biosimilarity of its proposed biosimilar, Epoetin ... (FDA) conditionally approved name of RETACRIT™, compared to ... study data were presented at the National Kidney ...
Breaking Medicine Technology:Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3
Cached News: